Equities

abrdn World Healthcare Fund

THW:NYQ

abrdn World Healthcare Fund

Actions
FinancialsClosed End Investments
  • Price (USD)12.67
  • Today's Change-0.204 / -1.59%
  • Shares traded73.43k
  • 1 Year change-9.85%
  • Beta0.8920
Data delayed at least 15 minutes, as of May 23 2024 19:52 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

abrdn World Healthcare Fund (the Fund), formerly Tekla World Healthcare Fund, is a non-diversified closed-end management investment company. The Fund's investment objective is to seek current income and long-term capital appreciation. The Fund invests in equity and debt of healthcare companies. The Fund is focused on investing at least 40% of its managed assets in companies organized or located outside of the United States or companies that do a substantial amount of business outside the United States. The Fund may invest up to 20% of managed assets, measured at the time of investment, in non-convertible debt of healthcare companies. The Fund may also invest up to 20% of managed assets in healthcare real estate investment trusts. The Fund invests in sectors, which include biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, life science tools and services, healthcare distributors, managed healthcare, and others. The Fund’s investment adviser is abrdn Inc.

  • Revenue in USD (TTM)12.78m
  • Net income in USD37.62m
  • Incorporated2015
  • Employees--
  • Location
    abrdn World Healthcare Fund1900 Market Street, Suite 200PHILADELPHIA 19103United StatesUSA
  • Phone+1 (617) 772-8515
  • Websitehttps://www.abrdnthw.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Royce Micro-Cap Trust Inc8.26m72.89m474.25m--6.680.9313--57.391.461.460.166210.470.0161--2.04--14.23--14.59--0.3882--882.04------0.0038--10.29--170.94------
PennantPark Investment Corp.149.37m59.95m477.44m0.007.960.952--3.200.91920.91922.297.690.1191--12.40--4.781.754.921.7952.4150.1440.1419.85--8.390.6051191.5738.496.07-36.65----1.09
Gladstone Capital Corporation93.80m68.62m480.34m73.006.711.12--5.123.293.294.5519.870.1241--9.851,284,890.009.086.179.176.2236.6535.9173.1654.71----0.461783.9736.8713.65114.2618.00--7.93
Abrdn Global Infrastructure Income Fund37.04m8.25m481.19m--58.320.9964--12.990.32730.32731.4719.160.1127--39.03--2.51--2.53--84.41--22.28----1.410.00--126.25--147.39------
PGIM Global High Yield Fund Inc48.12m48.71m483.72m--9.930.917--10.051.191.191.1812.890.0719------7.282.527.422.5670.9877.22101.2340.96----0.2156227.51-2.44-1.27136.056.11--52.59
BlackRock MuniYield Fund Inc37.44m15.50m489.81m--31.600.873--13.080.33890.33890.816517.760.0419--3.48--1.74--1.77--57.26--41.40----3.790.0595--------------
Nuveen New Jersey Quality Mncpl Inc Fund-100.00bn-100.00bn489.81m--------------------------------------------------------------
BlackRock Ltd Duration Income Trust-100.00bn-100.00bn491.03m0.00------------------------------------------------------------
abrdn World Healthcare Fund12.78m37.62m492.21m--12.961.10--38.530.99320.99320.335211.730.0222--4.48--6.533.716.583.78-6.2819.07294.44180.74----0.2116215.115.47-1.33159.873.10---0.4599
John Hancock Preferred Income Fund III-100.00bn-100.00bn492.88m--------------------------------------------------------------
Guggenheim Active Allocation Fund48.90m47.93m495.36m--10.340.9389--10.131.451.451.4816.000.0675--2.50--6.61--9.04--59.37--98.02------0.2055--183.02--89.63------
Invesco Trst fr Invstmt Grd Nw Yrk Mncpl-100.00bn-100.00bn496.57m--------------------------------------------------------------
BlackRock Municipal Income Trust II40.27m15.70m504.00m0.0032.110.8652--12.520.32890.32890.838912.200.0442--15.89--1.72-0.54661.74-0.55350.6467.2438.98-14.20--4.590.3012--7.349.8496.90-----11.10
Invesco Quality Municipal Income Trust40.40m44.74m504.51m0.0011.280.8591--12.490.8460.8460.763811.100.0457--10.03--5.060.86295.120.868955.7466.12110.7521.36----0.3288310.17-2.38-3.72150.9512.96---8.92
Thornburg Income Builder Opportunts Trst31.95m71.19m511.06m--7.180.8668--16.002.222.220.995818.380.0555--6.08--12.36--12.38--77.26--222.83------0.00--0.0323--192.83------
Data as of May 23 2024. Currency figures normalised to abrdn World Healthcare Fund's reporting currency: US Dollar USD

Institutional shareholders

7.70%Per cent of shares held by top holders
HolderShares% Held
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024892.64k2.35%
RBC Capital Markets LLC (Investment Management)as of 31 Mar 2024480.92k1.27%
LPL Financial LLCas of 31 Mar 2024299.58k0.79%
Corecap Advisors LLCas of 31 Dec 2023280.65k0.74%
Commonwealth Equity Services LLCas of 31 Mar 2024232.51k0.61%
UBS Financial Services, Inc.as of 31 Mar 2024211.24k0.56%
Steward Partners Investment Advisory LLCas of 31 Mar 2024178.65k0.47%
Raymond James & Associates, Inc. (Invt Mgmt)as of 31 Mar 2024148.30k0.39%
Cambridge Investment Research Advisors, Inc.as of 31 Mar 2024107.17k0.28%
NewEdge Wealth LLCas of 31 Mar 202492.96k0.25%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.